• search

Ranbaxy gets USFDA nod to market Loperamide Hydrochloride

Written by: Staff

Mumbai, Sept 11 (UNI) Ranbaxy Laboratories today received approval from the US Food and Drug Administration to manufacture and market tablets used to control symptoms of diarrhea plus bloating, pressure, and cramps commonly referred to as gas.

Announcing this to the Bombay Stock Exchange, the company informed that the tablets, known as Loperamide Hydrochloride and Simethicone Tablets (OTC), in medical terminology, had achieved total sales of USD 25.3 million, in the OTC market.

''Ohm will again be a leading participant in the launch of another successful and proven Loperamide formulation.'' senior director (OTC sales and marketing) of Ohm Laboratories, Robert Haywood said.

Ohm Laboratories, based in North Brunswick, New Jersey, USA, is a wholly owned subsidiary of Ranbaxy. Ohm is engaged in the sale and distribution of generic and branded OTC products in the US.


For Daily Alerts
Get Instant News Updates
Notification Settings X
Time Settings
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Oneindia sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Oneindia website. However, you can change your cookie settings at any time. Learn more